IgG4-related sclerosing cholangitis

Annals of Hepatology

Volumn 10, Issue 4, 2011, Pages 552-555

  Kamisawa, Terumi ^a   Tabata, Taku ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; STEROID;

ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE PANCREATITIS; BILE DUCT OBSTRUCTION; CHOLANGIOGRAPHY; DIFFERENTIAL DIAGNOSIS; ENTERITIS; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN G4 RELATED SCLEROSING CHOLANGITIS; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; OBSTRUCTIVE JAUNDICE; PANCREATICODUODENECTOMY; PANCREATOGRAPHY; PRIMARY SCLEROSING CHOLANGITIS; SCLEROSING CHOLANGITIS; STEROID THERAPY;

EID: 80052742670     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31524-8     Document Type: Article

References (25)

1. Okazaki K, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 2009; 38: 849-66.
2. Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Nat Rev Gastroenterol Hepatol 2010; 7: 401-9.
3. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991; 22: 387-95.
4. Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003; 52: 683-7.
5. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-4.
6. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006; 41: 613-25.
7. Nakazawa T, Ando T, Hayashi K, Naitoh I, Ohara H, Joh T. Diagnostic procedure for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 2011; 18: 127-36.
8. Kamisawa T, Takuma K, Anjiki H, Egawa N, Kurata M, Honda G, et al. Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis. World J Gastroenterol 2009; 15: 2357-60.
9. Hirano K, Tada M, Isayama H, Yamamoto K, Mizuno S, Yagioka H, et al. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis. Gastrointest Endosc 2010; 71: 85-90.
10. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Current consepts. Primary sclerosing cholangitis. N Engl J Med 1984; 310: 899-903.
11. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing scholangitis: natural history, prognostic factors and survgival analysis. Hepatology 1989; 10: 430-6.
12. Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan. Presence of a group without pancreatic involvement in older patients. Hepatol Res 2004; 29: 153-9.
13. Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005; 30: 20-5.
14. Nishino T, Oyama H, Hashimoto E, Toki F, Oi I, Kobayashi M, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 2007; 42: 550-9.
15. Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006; 101: 2070-5.
16. Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 2004; 60: 937-44.
17. Naitoh I, Nakazawa T, Ohara H, Ando T, Hayashi K, Tanaka H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol 2009; 44: 1147-55.
18. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134: 706-15.
19. Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A. A new diagnostic endoscopic tool for autoimmune pancreatitis. Gastrointest Endosc 2008; 68: 358-61.
20. Kubota K, Kato S, Akiyama T, Yoneda M, Fujita K, Ogawa M, et al. Differentiating sclerosing cholangitis caused by autoimmune pancreatitis and primary sclerosing cholangitis according to endoscopic duodenal papillary features. Gastrointest Endosc 2008; 68: 1204-8.
21. Moon SH, Kim MH, Park DH, Hwang CY, Park SJ, Lee SS, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008; 57: 1704-12.
22. Clendenon JN, Aranda-Michel J, Krishna M, Taner CB, Willingham DL. Recurrent liver failure caused by IgG4 associated cholangitis. Ann Hepatol 2011; 10 (4): 562-4.
23. Koyabu M, Uchida K, Fukata N, Kusuda T, Ikeura T, Sakaguchi Y, et al. Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells. J Gastroenterol 2010; 45: 122-9.
24. Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, et al. Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol 2011; 46(Suppl. 1): 48-55.
25. Abdo AA, Bain VG, Kichian K, Lee SS. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome. Hepatology 2002; 36: 1393-9.